Promising Dystrophy Drug Clears Early Test
42363
Researchers in the Netherlands have developed a drug that may eventually be used to treat children with a severe and fatal type of muscular dystrophy.
400965
Medarex's partner advances one of its compounds into later stage clinical testing.
233864
Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) faces an important regulatory test Aug. 27 when a Food and Drug Administration advisory panel will review Macugen, the company&#39;s experimental drug intended
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
596420
LONDON - The Football Association announced yesterday that it will introduce a test for the banned drug erythropoietin (EPO) &#39;in the near future&#39;.
726966
The US Food and Drug Administration cleared the first DNA microarray test for use by physicians in making treatment decisions based on a patient&#39;s genes.
714179
SAN FRANCISCO - Genzyme Corp. won clearance from US regulators to market Renvela, a medicine for patients on kidney dialysis.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
722014
New drugs that mimic mutations found in buff animals could treat muscle-wasting diseases.
194514
UNDATED A small, preliminary study shows an experimental drug can offer relief to victims of the poorly understood autoimmune illness Chron&#39;s (krohnz) disease.
30062
By Reuters. In the first major trial to test a drug only in blacks, an experimental drug developed by NitroMed Inc., combined with standard therapy, helped heart failure patients live significantly longer, researchers said yesterday.
18088
A popular baldness drug taken by more  than 4 million men worldwide can mask an important marker used  in screening tests to detect prostate cancer, scientists said  on Monday.
705948
ROCKVILLE, Md.  - An experimental drug developed  by Eyetech Pharmaceuticals Inc. and Pfizer Inc. for preserving  vision in the elderly received a generally positive review from  a U.S. advisory panel on Friday.
284659
MONDAY, Oct. 2 (HealthDay News) -- An antibiotic called siomycin A shows early promise as an anti-cancer agent, say researchers at the University of Illinois at Chicago College of Medicine.
468910
Biomira reports favorable Phase II test results.
556626
Human trials are now beginning on a compound that promises to be the first new tuberculosis drug in four decades, one that has been shown in animal experiments to clear TB infections twice as fast as existing medications.
70738
A new compound gives hope as the disease has become increasingly resistant to current drugs. By Thomas H. Maugh II / Los Angeles Times.